The Functional assessment of Cancer Therapy-Prostate (FACT-P) & Trial Outcomes Index (TOI): a Rasch analysis

被引：0
|
作者：
Smith, Adam B. [1 ]
Cocks, Kim [2 ]
Parry, David [3 ]
Taylor, Matthew [4 ]
机构：
[1] Univ York, York Hlth Econ Consortium, York YO10 5DD, N Yorkshire, England
[2] Univ York, York YO10 5DD, N Yorkshire, England
[3] AstraZeneca Pharmaceut Ltd, Bangalore, Karnataka, India
[4] York Hlth Econ Consortium, New York, NY USA
来源：
QUALITY OF LIFE RESEARCH | 2014年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
1086
引用
收藏
页码：99 / 99
页数：1
相关论文
共 50 条
  • [41] Symptom Burden after Living Donor Kidney Transplant Measured with the Functional Assessment of Cancer Therapy - Kidney Symptom Index is Associated with Worse Transplant Outcomes.
    Peipert, J.
    Caicedo-Ramirez, J.
    Ensor, K.
    Friedewald, J.
    Abecassis, M.
    Cella, D.
    Ladner, D.
    Butt, Z.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 656 - 656
  • [42] Transcriptomic Signatures Associated With Outcomes in Recurrent Prostate Cancer Treated With Salvage Radiation, Androgen-Deprivation Therapy, and Enzalutamide: Correlative Analysis of the STREAM Trial
    Bitting, Rhonda L.
    Wu, Yuan
    Somarelli, Jason A.
    Proudfoot, James A.
    Liu, Yang
    Davicioni, Elai
    George, Daniel J.
    Armstrong, Andrew J.
    [J]. JCO PRECISION ONCOLOGY, 2023, 7
  • [43] Functional Outcomes After De-escalated Chemoradiation Therapy for Human Papillomavirus-Positive Oropharyngeal Cancer: Secondary Analysis of a Phase 2 Trial
    Hegde, John V.
    Shaverdian, Narek
    Felix, Carol
    Wang, Pin-Chieh
    Veruttipong, Darlene
    Hsu, Sophia
    Riess, Jonathan W.
    Rao, Shyam D.
    Daly, Megan E.
    Chen, Allen M.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 100 (03): : 647 - 651
  • [44] EVIDENCE TO SUPPORT THE USE OF THE FUNCTIONAL ASSESSMENT OF CANCER THERAPY - GENERAL ITEM GP5 (FACT-GP5) TO ASSESS COMPARATIVE TOLERABILITY ENDPOINT: RESULTS FROM THE LIBRETTO-531 TRIAL
    Regnault, A.
    Bunod, L.
    Loubert, A.
    Gilligan, A.
    Maeda, P.
    Lin, Y.
    Hess, L.
    Payakachat, N.
    [J]. VALUE IN HEALTH, 2024, 27 (06) : S343 - S344
  • [45] Focal Therapy for Prostate Cancer with In-Bore MR-guided Focused Ultrasound: Two-Year Follow-up of a Phase I Trial-Complications and Functional Outcomes
    Tay, Kae Jack
    Cheng, Christopher W. S.
    Lau, Weber K. O.
    Khoo, James
    Thng, Choon Hua
    Kwek, Jin Wei
    [J]. RADIOLOGY, 2017, 285 (02) : 620 - 628
  • [46] MAPPING THE FUNCTIONAL ASSESSMENT OF CANCER THERAPY - BREAST (FACT-B) TO THE 5-LEVEL EUROQOL GROUP'S 5-DIMENTION QUESTIONNAIRE (EQ-5D) INDEX IN A MULTI-ETHNIC ASIAN BREAST CANCER PATIENTS
    Lee, C. F.
    Gandhi, M.
    Cheung, Y. B.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A738 - A738
  • [47] Functional Outcomes from a Phase II Trial of Adaptive Deescalation of Radiation Therapy Dose in p16+Oropharyngeal Cancer Patients Demonstrating Favorable Mid -treatment Nodal Response
    Hung, C.
    Kim, J. K.
    Mojica, J.
    Parody, S.
    Seo, J. Y.
    Tam, M.
    Oh, C.
    Concert, C. M.
    Vaezi, A. E.
    Li, Z.
    Tran, T.
    Feron-Rigodon, M.
    Givi, B.
    Jacobson, A.
    Persky, M.
    Persky, M.
    Harrison, L. B.
    Duvvuri, U.
    Hu, K. S.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 118 (05): : E62 - E62
  • [48] Phase 3 Assessment of the Automated Bone Scan Index as a Prognostic Imaging Biomarker of Overall Survival in Men With Metastatic Castration-Resistant Prostate Cancer A Secondary Analysis of a Randomized Clinical Trial
    Armstrong, Andrew J.
    Anand, Aseem
    Edenbrandt, Lars
    Bondesson, Eva
    Bjartell, Anders
    Widmark, Anders
    Sternberg, Cora N.
    Pili, Roberto
    Tuvesson, Helen
    Nordle, Orjan
    Carducci, Michael A.
    Morris, Michael J.
    [J]. JAMA ONCOLOGY, 2018, 4 (07) : 944 - 951
  • [49] Comparative effectiveness analysis of oncological and functional outcomes after salvage radical treatment with surgery or radiotherapy following primary focal or whole-gland ablative therapy for localised prostate cancer
    Nathan, A.
    Ng, A.
    Mitra, A.
    Davda, R.
    Sooriakumaran, P.
    Patel, S.
    Fricker, M.
    Kelly, J.
    Shaw, G.
    Rajan, P.
    Sridhar, A.
    Nathan, S.
    Payne, H.
    [J]. EUROPEAN UROLOGY, 2022, 81 : S1417 - S1417
  • [50] EXTERNAL VALIDATION OF A RISK SCORE PREDICTING FAILURE AFTER SALVAGE FOCAL THERAPY FOR LOCALIZED RADIORECURRENT PROSTATE CANCER: AN ANALYSIS FROM THE FOCAL RECURRENT ASSESSMENT AND SALVAGE TREATMENT (FORECAST) TRIAL
    Light, Alexander
    Peters, Max
    Kanthabalan, Abi
    Pavlou, Menelaos
    Omar, Rumana
    Adeleke, Sola
    Giganti, Francesco
    Brew-Graves, Chris
    Emara, Amr
    Haroon, Athar
    Latifoltojar, Arash
    Sidhu, Harbir
    Freeman, Alex
    Orczyk, Clement
    Nikapota, Ashok
    Dudderidge, Tim
    Hindley, Richard G.
    Payne, Heather
    Mitra, Anita
    Bomanji, Jamshed
    Winkler, Mathias
    Horan, Gail
    Punwani, Shonit
    Ahmed, Hashim U.
    Shah, Taimur T.
    [J]. JOURNAL OF UROLOGY, 2023, 209 : E1035 - E1036
12345